Heterocyclic compound, and composition for treating inflammatory diseases using same
申请人:Gwak Hyung Sub
公开号:US08809541B2
公开(公告)日:2014-08-19
Provided are heterocyclic compounds, having effects of treating and preventing inflammatory diseases and treating skin wounds, and particularly, exhibiting effects of recovering disrupted skin barriers, mitigating inflammation, and pruritus. Also, a composition containing the compound as an effective component can be used to mitigate various inflammatory diseases and protease activated receptor-2 (PAR-2)-overexpressed diseases, and can be particularly used as a composition having an anti-inflammatory function in inflammatory skin diseases including atopic dermatitis and the like, by inhibiting PAR-2 activity.
1H-Benzo[d]imidazol-5-yl compounds and composition for treating inflammatory diseases
申请人:Neopharm Co., Ltd.
公开号:EP2610255B1
公开(公告)日:2016-02-24
US8809541B2
申请人:——
公开号:US8809541B2
公开(公告)日:2014-08-19
[EN] NOVEL HETEROCYCLIC COMPOUND, AND COMPOSITION FOR TREATING INFLAMMATORY DISEASES USING SAME<br/>[FR] NOUVEAU COMPOSÉ HÉTÉROCYCLIQUE, ET COMPOSITION POUR TRAITER DES MALADIES INFLAMMATOIRES UTILISANT LE MÊME
申请人:NEOPHARM CO LTD
公开号:WO2012026766A2
公开(公告)日:2012-03-01
본 발명에 따른 헤테로고리 화합물은 염증성 질환의 치료 및 예방 효과와 피부 상처치유효과를 갖으며, 특히 염증성 피부 질환에 있어 손상된 피부장벽의 회복효과와 염증 완화, 소양증 완화 효과를 나타낸다. 본 발명의 화합물을 유효성분으로 하는 조성물은 다양한 염증성 질환 및 PAR-2 (protease activated receptor-2) 수용체의 발현이 증가된 질환을 완화하기 위해 사용할 수 있으며, 특히 피부에서 PAR-2의 활성을 저해하여 아토피 피부염 등을 포함한 염증성 피부질환에 있어 항염 기능을 지닌 조성물로서 사용이 가능하다.
NOVEL HETEROCYCLIC COMPOUND, AND COMPOSITION FOR TREATING INFLAMMATORY DISEASES USING SAME
申请人:Gwak Hyung Sub
公开号:US20130158047A1
公开(公告)日:2013-06-20
Provided are heterocyclic compounds, having effects of treating and preventing inflammatory diseases and treating skin wounds, and particularly, exhibiting effects of recovering disrupted skin barriers, mitigating inflammation, and pruritus. Also, a composition containing the compound as an effective component can be used to mitigate various inflammatory diseases and protease activated receptor-2 (PAR-2)-overexpressed diseases, and can be particularly used as a composition having an anti-inflammatory function in inflammatory skin diseases including atopic dermatitis and the like, by inhibiting PAR-2 activity.